Schmid R, et al. - Researchers conducted this retrospective noncomparative open-label clinical trial to asssess the impact of a novel technique to correct presbyopia. A phakic IOL (presbyopic IPCL; implantable phakic contact lens) with a diffractive optic was implanted and its impact on visual acuity, refraction, patient satisfaction in patients striving for spectacle-independence has been assessed. The posterior chamber had a presbyopic IPCL implanted in 16 eyes of 8 patients (average age 47 years). Nine of the 16 eyes were emmetropic and uncorrected distance visual acuity was at least 0.8 at follow-up four weeks after surgery. Near vision in all patients was outstanding, without the need to wear reading glasses. No major complaint was made about halos or glare. Findings suggested that the presbyopic IPCL will provide good visual acuity and spectacle-independence to the presbyopic patient for far and near distance. During the surgical procedure and the short follow-up period, the authors found this novel technique to have a good safety profile. Further follow-up in the long term is mandatory.